COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 01:03, il y a 2 années 8 mois ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX Rosen Law Firm, a global investor rights law firm, reminds Eagle Pharmaceuticals, Inc. investors of February 9, 2024 lead plaintiff deadline in securities class action. The lawsuit claims investors suffered damages due to false and misleading statements Rosen Law Firm Securities Class Action Investor Rights Misleading Statements Eagle Pharmaceuticals Inc.
COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 00:05, il y a 2 années 8 mois ROSEN, A LONGSTANDING LAW FIRM, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important February 2 Deadline in Securities Class Action First Filed by the Firm - EH Rosen Law Firm encourages EHang Holdings Limited investors to secure counsel before important February 2 deadline in securities class action. Investors may be entitled to compensation. Details of the case include misleading statements about business operations and prospects Rosen Law Firm Securities Class Action EHang Holdings Limited Investment Fraud Business Litigation
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 18:03, il y a 2 années 8 mois ROSEN, A LEADING LAW FIRM, Encourages Assertio Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASRT Rosen Law Firm encourages Assertio Holdings, Inc. investors to secure counsel before important deadline in securities class action. Investors may be entitled to compensation. Details of the case include misleading statements and unsustainable reliance on pharmaceutical products Rosen Law Firm Securities Class Action Compensation Assertio Holdings Inc Misleading Statements
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 17:37, il y a 2 années 8 mois ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Inspired Entertainment, Inc. Investors to Inquire About Securities Class Action Investigation - INSE The Rosen Law Firm, P.A., a globally respected law firm, continues to investigate potential securities claims on behalf of shareholders of Inspired Entertainment, Inc. (NASDAQ: INSE) resulting from allegations that the company may have issued materially misleading business information to the investing public Rosen Law Firm Securities Class Action Investor Rights Inspired Entertainment Accounting Errors
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 16:34, il y a 2 années 8 mois EXFY DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Expensify, Inc. Investors to Secure Counsel Before Important January 29 Deadline in Securities Class Action - EXFY Rosen Law Firm alerts Expensify, Inc. investors to January 29 lead plaintiff deadline. Lawsuit alleges negligence in IPO Offering Documents and false statements about business prospects Rosen Law Firm Securities Class Action Expensify Inc. IPO Offering Documents Negligence Lawsuit
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 15:35, il y a 2 années 8 mois ROSEN, LEADING INVESTOR COUNSEL, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important Deadline in Securities Class Action - EVVTY Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares of Evolution AB (publ) between February 14, 2019 and October 25, 2023. Investors may seek compensation without out of pocket fees. To join the class action, visit https://rosenlegal.com/submit-form/?case_id=22119 or contact Phillip Kim, Esq. at 866-767-3653 or pkim@rosenlegal.com Rosen Law Firm Securities Class Action Investor Rights Class Action Lawsuit Evolution AB
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 15:04, il y a 2 années 8 mois ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR Rosen Law Firm files class action lawsuit on behalf of AlloVir, Inc. investors. Lawsuit alleges false statements regarding posoleucel Phase 3 Studies. Investors urged to secure counsel before March 19, 2024 deadline Rosen Law Firm Investor Rights Securities Litigation Class Action Lawsuit AlloVir Inc.
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 15:04, il y a 2 années 8 mois ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm reminds BioNTech SE investors of the lead plaintiff deadline in securities class action. Investors may be entitled to compensation Rosen Law Firm BioNTech SE Securities Class Action Lead Plaintiff Deadline Investor Compensation
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 14:37, il y a 2 années 8 mois ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Future FinTech Group Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FTFT Rosen Law Firm encourages Future FinTech Group Inc. investors with losses to secure counsel before the important deadline in securities class action first filed by the firm. Investors may be entitled to compensation. The firm has a track record of success in leadership roles and represents investors globally Investors Rosen Law Firm Securities Class Action Future FinTech Group Inc. Class Plaintiff Deadline
COMMUNIQUÉ DE PRESSE publié le 28/01/2024 à 02:03, il y a 2 années 8 mois GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm encourages BioNTech SE investors to secure counsel before important deadline in securities class action. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement Investors Rosen Law Firm BioNTech SE Securities Class Action Compensation
Publié le 23/10/2026 à 07:00, il y a 1 heure 9 minutes Safran publie son chiffre d’affaires du 3e trimestre 2026
Publié le 22/10/2026 à 18:00, il y a 14 heures 9 minutes THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Publié le 22/10/2026 à 18:00, il y a 14 heures 9 minutes THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Publié le 22/10/2026 à 18:00, il y a 14 heures 9 minutes bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Publié le 23/10/2026 à 02:20, il y a 5 heures 49 minutes Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Publié le 22/10/2026 à 23:30, il y a 8 heures 39 minutes Cypher Announces Subscription Receipt Offering
Publié le 22/10/2026 à 22:30, il y a 9 heures 39 minutes Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Publié le 22/10/2026 à 16:00, il y a 16 heures 9 minutes Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Publié le 22/10/2026 à 14:30, il y a 17 heures 39 minutes Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Publié le 23/10/2026 à 07:00, il y a 1 heure 8 minutes EQS-Adhoc: BB Biotech AG publishes its interim report
Publié le 23/10/2026 à 07:00, il y a 1 heure 9 minutes ATOSS Software SE: Revenue growth and high profitability in the third quarter put ATOSS on track for another record year
Publié le 23/10/2026 à 07:00, il y a 1 heure 9 minutes BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment
Publié le 23/10/2026 à 06:45, il y a 1 heure 23 minutes GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Publié le 23/10/2026 à 06:30, il y a 1 heure 38 minutes HBM Healthcare Investments publishes Half-Year Report as at 30 September 2026 with key figures for the first six months of the 2026/2027 financial year